NCT00955721 A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00955149 Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) Status COMPLETED Phase PHASE1
NCT00948935 Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00907413 Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma Status TERMINATED Phase PHASE3
NCT00797121 Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma Status UNKNOWN Phase PHASE4
NCT00779454 Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT00733200 Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? Status COMPLETED Phase NA
NCT00713687 Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma Status WITHDRAWN Phase PHASE2
NCT00660140 Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00653978 Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures Status UNKNOWN Phase PHASE3
NCT00630890 Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) Status TERMINATED Phase PHASE1
NCT00604266 Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study Status WITHDRAWN Phase N/A
NCT00540735 Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas Status TERMINATED Phase PHASE3
NCT00465023 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases Status COMPLETED Phase NA
NCT00414843 Storage of Bile From Routine Procedures to Study Risk Factors Status TERMINATED Phase N/A
NCT00350961 Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma Status COMPLETED Phase PHASE1/PHASE2